SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-001413
Filing Date
2024-01-16
Accepted
2024-01-16 17:00:41
Documents
3
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A mbrx20240108_def14a.htm DEF 14A 116113
2 a01.jpg GRAPHIC 157880
3 a02.jpg GRAPHIC 149052
  Complete submission text file 0001437749-24-001413.txt   539731
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37758 | Film No.: 24535825
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)